MKI67 and cancer: A significantly higher proportion of cases expressed PgR and had a Ki67 ≤ 20% among screen-detected cancers compared with symptomatic tumors (78.1% v 68%, P = .04; and 57.1% v 44.1%, P = .02, respectively).